Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure?

Author： Di Lenarda Andrea   Sabbadini Gastone   Sinagra Gianfranco  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.2, 2004-03, pp. : 91-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do beta-blockers have a role in the treatment of chronic heart failure?

By Panfilov V.   Olsson G.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 1, 1997-01 ,pp. : 23-30

Informa Healthcare

Access to resources Recommend Favorite

Beta‐Blockers for Treatment of Heart Failure in the Elderly

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 36, Iss. 3, 2006-09 ,pp. : 229-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Relevance of Differences between Various Beta-Blockers

By  

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Beta-blockers: not the alpha male in matters of the heart

By  

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

-Blockers in Heart Failure: The ‘New Wave’ of Clinical Trials

By Krum H.  

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 203-210

Adis International

Access to resources Recommend Favorite